Skip to main content

and
  1. Article

    Open Access

    Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells

    Breast cancer (BC) cells secrete soluble factors that accelerate osteoclast (OC) differentiation, leading to the formation of osteolytic bone metastases. In the BOLERO-2 trial, BC patients with bone involvemen...

    Valeria Simone, Sabino Ciavarella, Oronzo Brunetti, Annalisa Savonarola in BMC Cancer (2015)